Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to 0.21.

  • Immucell's Debt Ratio fell 1538.59% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year decrease of 1538.59%. This contributed to the annual value of 0.23 for FY2024, which is 1447.62% down from last year.
  • Latest data reveals that Immucell reported Debt Ratio of 0.21 as of Q3 2025, which was down 1538.59% from 0.21 recorded in Q2 2025.
  • Immucell's Debt Ratio's 5-year high stood at 0.28 during Q3 2023, with a 5-year trough of 0.21 in Q4 2021.
  • In the last 5 years, Immucell's Debt Ratio had a median value of 0.23 in 2023 and averaged 0.23.
  • As far as peak fluctuations go, Immucell's Debt Ratio surged by 2245.36% in 2023, and later crashed by 2203.67% in 2025.
  • Over the past 5 years, Immucell's Debt Ratio (Quarter) stood at 0.21 in 2021, then rose by 10.95% to 0.23 in 2022, then grew by 19.81% to 0.27 in 2023, then dropped by 14.48% to 0.23 in 2024, then dropped by 11.18% to 0.21 in 2025.
  • Its last three reported values are 0.21 in Q3 2025, 0.21 for Q2 2025, and 0.22 during Q1 2025.